Guangdong True Health Medical Technology Development Co., Ltd. (TH Medical) announced that it has signed a sales contract with an independent third-party buyer for its puncture surgical navigation and positioning system. The agreement carries a maximum contract value of RMB 100.00 million and provides for staged product deliveries in the near term.
The puncture surgical navigation and positioning system is identified as one of TH Medical’s core business lines. Management highlighted that the transaction demonstrates strong market acceptance of the company’s technology and reinforces its competitive position in the puncture surgical robot segment, underpinning future expansion plans.
The voluntary disclosure was approved by the company’s board of directors and released on 31 August 2026. TH Medical is a joint-stock company incorporated in the People’s Republic of China; its Hong Kong listing trades under the name TH MEDICAL-B (stock code: 02697).